Print
Email
Cubist Pharmaceuticals Inc. has a market cap of $2.58 billion; its shares were traded at around $41.89 with a P/E ratio of 26.02 and P/S ratio of 4.05.
This is the annual revenues and earnings per share of CBST over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of CBST.
CEO Recent Trades:
- President and CEO Michael W Bonney sold 150,000 shares of CBST stock on 12/20/2011 at the average price of 38.69. Michael W Bonney owns at least 135,433 shares after this. The price of the stock has increased by 8.27% since.
This is the insider trade history vs. stock price of CBST. For the complete insider trading history of CBST, click here.
Directors and Officers Recent Trades:
- Director Leon O Jr Moulder bought 5,000 shares of CBST stock on 11/04/2011 at the average price of 36.78. Leon O Jr Moulder owns at least 5,883 shares after this. The price of the stock has increased by 13.89% since.
- Director Nancy J Hutson bought 1,500 shares of CBST stock on 10/26/2011 at the average price of 38.66. Nancy J Hutson owns at least 3,500 shares after this. The price of the stock has increased by 8.35% since.
- EVP, COO Robert J Perez sold 14,400 shares of CBST stock on 01/10/2012 at the average price of 40.99. Robert J Perez owns at least 25,125 shares after this. The price of the stock has increased by 2.2% since.
- SVP, Commercial Operations Gregory Stea sold 10,500 shares of CBST stock on 01/10/2012 at the average price of 40.94. Gregory Stea owns at least 8,817 shares after this. The price of the stock has increased by 2.32% since.
- Director Martin Rosenberg sold 10,000 shares of CBST stock on 01/03/2012 at the average price of 40.08. Martin Rosenberg owns at least 4,658 shares after this. The price of the stock has increased by 4.52% since.
For the complete insider trading history of CBST, click here.
Subscribe RSS
